Directions in ML: AutoML & Interpretability: Powering the machine learning revolution in healthcare

AutoML and interpretability are both fundamental to the successful uptake of machine learning by non-expert end users. The former will lower barriers to entry and unlock potent new capabilities that are out of reach when working with ad-hoc models, while the latter will ensure that outputs are transparent, trustworthy, and meaningful. In healthcare, AutoML and interpretability are already beginning to empower the clinical community by enabling the crafting of actionable analytics that can inform and improve decision-making by clinicians, administrators, researchers, policymakers, and beyond.

This talk presents state-of-the-art AutoML and interpretability methods for healthcare developed in our lab and how they have been applied in various clinical settings (including cancer, cardiovascular disease, cystic fibrosis, and recently Covid-19), and then explains how these approaches form part of a broader vision for the future of machine learning in healthcare.

Learn more about the 2020-2021 Directions in ML: AutoML and Automating Algorithms virtual speaker series: https://aka.ms/diml (opens in new tab)

Date:

October 26, 2020

Haut-parleurs:

Mihaela van der Schaar

Affiliation:

University of Cambridge, UCLA, and The Alan Turing Institute